Literature DB >> 6218859

Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?

G R Venning.   

Abstract

The process of discovery of 18 important adverse drug reactions was reviewed. For each adverse reaction the dates were noted of the report which first alerted the medical profession to the suspected reaction, the report which resulted in verification of causality beyond reasonable doubt, and the first regulatory action or warning to the medical profession in Britain by the Committee on the Safety of Medicines.

Mesh:

Substances:

Year:  1983        PMID: 6218859      PMCID: PMC1546494          DOI: 10.1136/bmj.286.6361.289

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  36 in total

1.  Oral contraceptives and death from myocardial infarction.

Authors:  J I Mann; W H Inman
Journal:  Br Med J       Date:  1975-05-03

2.  Myocardial infarction in young women with special reference to oral contraceptive practice.

Authors:  J I Mann; M P Vessey; M Thorogood; S R Doll
Journal:  Br Med J       Date:  1975-05-03

3.  Coronary thrombosis and Conovide.

Authors:  J BOYCE; J W FAWCETT; E W NOALL
Journal:  Lancet       Date:  1963-01-12       Impact factor: 79.321

4.  METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.

Authors:  J R GRAHAM
Journal:  N Engl J Med       Date:  1964-01-09       Impact factor: 91.245

5.  THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.

Authors:  D J FINNEY
Journal:  J Chronic Dis       Date:  1965-01

6.  Clear-cell adenocarcinoma of the genital tract in young females. Registry report.

Authors:  A L Herbst; R J Kurman; R E Scully; D C Poskanzer
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

7.  Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma.

Authors:  P D Stolley
Journal:  Am Rev Respir Dis       Date:  1972-06

8.  Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas).

Authors:  A L Herbst; R E Scully
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

9.  Fibrotic disorders associated with methysergide therapy for headache.

Authors:  J R Graham; H I Suby; P R LeCompte; N L Sadowsky
Journal:  N Engl J Med       Date:  1966-02-17       Impact factor: 91.245

10.  Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

Authors:  W H Inman; M P Vessey
Journal:  Br Med J       Date:  1968-04-27
View more
  11 in total

Review 1.  Case-population studies in pharmacoepidemiology.

Authors:  Dolors Capellà; Consuelo Pedrós; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Pharmaco-epidemiological perspectives.

Authors:  U Bergman
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

3.  [Adverse drugs reactions: diagnosis and assessment].

Authors:  P A Thürmann
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

4.  Signal detection: historical background.

Authors:  Toine C G Egberts
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  [Detection and evaluation of adverse drug reactions].

Authors:  P A Thürmann; K Schmitt
Journal:  Med Klin (Munich)       Date:  1998-11-15

6.  Spontaneous reporting of adverse drug reactions. I: the data.

Authors:  M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

Review 7.  Rare and serious adverse reactions.

Authors:  G R Venning
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

Review 8.  New drugs. Adverse reactions. I.

Authors:  D N Bateman; S Chaplin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

Review 9.  Does proof of casualty ever exist in pharmacovigilance?

Authors:  M Auriche; E Loupi
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

10.  Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.